Tyra Bioscience, Inc TYRA 深 沪
等待开盘 04-01 09:30:00 美东时间
38.30
+3.700
+10.69%
华盛通- 最 高38.45
- 今 开35.99
- 成交量 132.27万股
- 最 低 34.84
- 昨 收 34.60
- 总市值 20.63亿
- 52周最高 39.15
- 市盈率 静 --
- 换手率 2.46%
- 52周最低 7.80
- 委 比 70.21%
- 总股本 5386.71万
- 历史最高 39.15
- 量 比 1.55
- 振 幅 10.43%
- 历史最低 4.93
- 每 手 1
- 风险率 9.26%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股大行评级 | 小摩、瑞穗等下调阿里目标价最低至164美元；达登饭店、联邦快递、林肯教育服务、Planet Labs等获多家大行上调目标价
今日重点评级关注：瑞穗：维持RELMADA THERAPEUTICS"跑赢大市"评级，目标价从10美元升至19美元；奥本海默：维持Pelthos Therapeutics"跑赢大市"评级，目标价从60美元升至62美元
03-23 13:53
Piper Sandler Maintains Overweight on Tyra Biosciences, Raises Price Target to $56
Piper Sandler analyst Allison Bratzel maintains Tyra Biosciences (NASDAQ:TYRA) with a Overweight and raises the price target from $42 to $56.
03-20 23:35
On March 4, 2026, Tyra Biosciences Agreed To Issue And Sell 4,000,000 Shares Of Common Stock To A Large Investment Management Firm At A Purchase Price Of $31.50 Per Share; Co. Expects To Receive $126.0M In Gross Proceeds Upon Settlement, Before Deducting Fees And Other Expenses Payable By It
https://www.sec.gov/ix?doc=/Archives/edgar/data/0001863127/000119312526091880/d48655d8k.htm
03-05 06:23
Tyra Biosciences Q4 EPS $(0.57) Misses $(0.55) Estimate
Tyra Biosciences (NASDAQ:TYRA) reported quarterly losses of $(0.57) per share which missed the analyst consensus estimate of $(0.55) by 4.2 percent. This is a 32.56 percent decrease over losses of $(0.43) per share from
03-03 05:18
Cantor Fitzgerald Initiates Coverage On Tyra Biosciences with Overweight Rating
Cantor Fitzgerald analyst Li Watsek initiates coverage on Tyra Biosciences (NASDAQ:TYRA) with a Overweight rating.
02-24 22:15
美股大行评级 | 潜在涨幅1226.53%！RenovoRx获Ascendiant Capital升目标价至13美元，维持"买入"评级
今日重点评级关注：Ascendiant Capital：维持RenovoRx"买入"评级，目标价从12.5美元升至13美元；Lake Street：维持Insight Molecular"买入"评级，目标价从8美元升至12美元
02-18 16:48
Wedbush Maintains Outperform on Tyra Biosciences, Raises Price Target to $53
Wedbush analyst Robert Driscoll maintains Tyra Biosciences (NASDAQ:TYRA) with a Outperform and raises the price target from $37 to $53.
02-13 23:02
美股大行评级 | 潜在涨幅213.87%！Wave Life Sciences获Canaccord Genuity升目标价至43美元，维持"买入"评级
今日重点评级关注：Canaccord Genuity：维持Wave Life Sciences Ltd."买入"评级，目标价从40美元升至43美元；花旗：维持Palantir Technologies"买入"评级，目标价从235美元升至260美元
02-04 12:15
Oppenheimer Maintains Outperform on Tyra Biosciences, Raises Price Target to $50
Oppenheimer analyst Matthew Biegler maintains Tyra Biosciences (NASDAQ:TYRA) with a Outperform and raises the price target from $36 to $50.
02-03 22:54
美股大行评级 | 希捷科技、德州仪器、HCA控股、通用汽车、波音、UPS等或多家机构上调目标价；布朗保险、康沃系统、Qorvo、联合健康等遭多家机构下调目标价
今日重点评级关注：Piper Sandler：维持Praxis Precision Medicine"超配"评级，目标价从450美元升至1200美元；Tigress Financial：维持Main International ETF"买入"评级，目标价从52美元升至66美元
01-29 11:06
